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Abstract
PURPOSE: Low serum vitamin D status has been associated with 
reduced muscle mass in observational studies although the relationship 
is controversial and a causal association cannot be determined from 
such observations. Two-sample Mendelian randomization (MR) was 
applied to assess the association between serum vitamin D (25(OH)D) 
and total, trunk, arm and leg fat-free mass (FFM).
METHODS: MR was implemented using summary-level data from 
the largest genome-wide association studies (GWAS) on vitamin 
D (n=73,699) and total, trunk, arm and leg FFM. Inverse variance 
weighted method (IVW) was used to estimate the causal estimates. 
Weighted median (WM)-based method, and MR-Egger, leave-one-out 
were applied as sensitivity analysis.
RESULTS: Genetically higher serum 25(OH)D levels had a positive 
effect on total (IVW = Beta: 0.042, p = 0.038), trunk (IVW = Beta: 
0.045, p = 0.023) and arm (right arm IVW = Beta: 0.044, p = 0.002; 
left arm IVW = Beta: 0.05, p = 0.005) FFM. However, the association 
with leg FFM was not significant (right leg IVW = Beta: 0.03, p 
= 0.238; left leg IVW = Beta: 0.039, p = 0.100). The likelihood of 
heterogeneity and pleiotropy was determined to be low (statistically 
non-significant), and the observed associations were not driven by 
single SNPs. Furthermore, MR pleiotropy residual sum and outlier test 
did not highlight any outliers.
CONCLUSIONS: Our results illustrate the potentially causal, positive 
effect of serum 25(OH)D concentration on total, trunk and upper body 
appendicular fat-free mass. 
Key  words :  Musc le  mass ,  Mende l ian  randomiza t ion , 
25-Hydroxyvitamin D, 25(OH)D, lean mass, fat-free mass.
Introduction
Vitamin D is an essential nutrient for human health with roles in multiple biological pathways and low vitamin D status is associated with multiple chronic 
diseases (1) as well as being associated with musculoskeletal 
health (2, 3) highlighting this nutrient’s significance in the 
global burden of disease. However, up to 40% of the European 
population may suffer from vitamin D insufficiency (serum 
25-hydroxy vitamin D [25(OH)D] concentration <50 nmol/L) 
(4) and vitamin D deficiency (25(OH)D concentration <30 
nmol/L)is widespread enough to be considered a global health 
issue (4-6).  
Loss of muscle mass directly affects muscle strength and 
physical function and as such, sarcopenia, the progressive 
loss of muscle mass and strength in aging, and frailty (7, 
8). Furthermore, muscle mass loss has been associated with 
a multitude of chronic conditions including cardiovascular 
disease (CVD) (9), type 2 diabetes mellitus (T2DM) (10), 
increased risk of falls and fractures (11), cognitive decline and 
depression (12, 13), and all-cause mortality (14). Older adults 
may spend more time indoors due to poor mobility/reduced 
muscle function which can further lead to an elevated risk of 
vitamin D inadequacy (15, 16), leading to a vicious cycle of 
vitamin D deficiency and loss of muscle mass.
Epidemiological studies suggest an association between 
low vitamin D status and reduced muscle mass (3, 17, 18) 
although some studies have found no such association (19, 
20). However, such studies are limited as observational data 
cannot determine whether an association is causal. Mendelian 
randomization (MR) analysis uses functional polymorphisms 
(single nucleotide polymorphisms (SNPs)) associated with 
specific changes in exposures (in this case, serum 25(OH)
D) as genetic instruments to determine whether the risk factor 
is a cause of the disease (21). A major advantage of MR 
analysis is that they are considerably less prone to confounding, 
residual bias, and reverse causation than conventional risk-
factor epidemiology (22). MR analysis may also circumvent 
the financial, logistical and ethical limitations of randomised 
controlled trials (RCTs) and additionally, the data from such 
studies can inform the design of pilot RCTs and clinical trials 
by providing information for the potential magnitude of effect 
of nutrients on a given outcome in specific populations (23).
In the present study, we used MR analysis to determine 
whether a potential causal relationship exists between serum 




A two-sample MR study design was used. In a 2-sample MR, 
the ssummary statistics are provided from various studies for 
the association of the genetic instruments with the exposure and 
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outcome. In our study, we obtained the summary statistics from 
the largest genome wide association studies (GWAS) on serum 
25(OH)D (exposure (24)) and FFM (outcome). We applied 
methods to estimate the unbiased effect of serum 25(OH)D on 
FFM (total, trunk, arms and legs,).
Genetic predictors of exposures
We used six SNPs identified to be associated with circulating 
25(OH)D concentration by the SUNLIGHT meta-GWAS, 
which are samples of European ancestry (79,366 discovery 
samples and 42,757 replication samples) (Table 1). GWAS 
were performed within each cohort according to a uniform 
analysis plan. Additive genetic models using linear regression 
on natural-log-transformed 25(OH)D were fitted and a fixed-
effects inverse variance weighted (IVW) meta-analysis across 
the contributing cohorts was performed (24).  
Association of genetic instruments with outcome
SNPs associated with bioelectrical-impedance-measured 
fat mass and total, trunk, arm and leg FFM were obtained 
from analyses by Neale Lab (http://www.nealelab.is). We 
retrieved the association of the six genetic instruments with 
SNPs associated with bioelectrical impedance measured FFM 
using data obtained from UK Biobank. Detailed descriptions 
of the methods used to measure body composition is available 
on the UK Biobank website (25). Briefly, whole body as 
well as site-specific (trunk, leg, arm) fat-free mass/fat mass 
were evaluated with bioelectrical-impedance analysis (Tanita 
BC418MA body composition analyser). Body composition of 
a subset of participants was also assessed using dual-energy 
X-ray absorptiometry (DXA) which showed high correlation 
with bio-impedance values (fat-free mass: r = 0.96) (25). The 
UK Biobank is a population-based cohort of approximately 
500,000 individuals; 54% are female, the average age is 57 
(range 37–73), while 94% report as being White British. 
Further details on the rationale, design and methodology for UK 
Biobank can be found elsewhere (26).
Mendelian Randomisation analysis
We combined the effect of six instruments using inverse 
variance weighted (IVW) method as implemented in Two 
Sample MR package of the statistical software, R (R Core 
Team, Vienna, Austria. https://www.R-project.org/). 
We assessed the heterogeneity using Q value for IVW. To 
address the potential effect of pleiotropic variants on the final 
effect estimate, we conducted sensitivity analysis including 
weighted median (WM) and MR-Egger. Sensitivity analysis 
was conducted using the leave-one-out method. The weighted 
median (WM) estimate, as the weighted median of the SNP-
specific estimates, provides correct estimates as long as SNPs 
accounting for ≥50% of the weight are valid instruments. WM 
MR allows some variants to be invalid instruments provided 
at least half are valid instruments. It uses inverse variance 
weights and bootstrapping to estimate confidence intervals 
(CIs) (27). MR-Egger has an ability to make estimates by 
assumption of all SNPs are invalid instruments as long as the 
assumption of instrument strength independent of direct effect 
(InSIDE) is satisfied (27). MR-Egger allows free estimation 
of the intercept, although further assumptions, such as the 
independence between instrument strength and direct effects, 
cannot be easily verified. Average directional pleiotropy across 
genetic variants was assessed from the p-value of the intercept 
term from MR-Egger (27). Causal estimates in MR Egger 
are less precise than those obtained by using IVW MR (28). 
Analysis using MR-Egger has a lower false positive rate but a 
higher false negative rate than IVW (29). 
Further, to assess heterogeneity between individual genetic 
variant estimates, we used the Q’ heterogeneity statistic [30] 
and the MR pleiotropy residual sum and outlier (MR-PRESSO) 
test (30). The Q’ statistic uses modified 2nd order weights 
that are a derivation of a Taylor series expansion and take into 
account uncertainty in both numerator and denominator of the 
instrumental variable ratio (this eases the no-measurement-error 
[NOME] assumption) (30). The MR-PRESSO framework relies 
on the regression of variant-outcome associations on variant-
exposure associations and implements a global heterogeneity 
test by comparing the observed distance (residual sums of 
squares) of all variants to the regression line with the distance 
expected under the null hypothesis of no pleiotropy (31). In 
case of evidence of horizontal pleiotropy, the test compares 
individual variants expected and observed distributions to 
identify outlier variants. Further we applied on MR-Robust 
Adjusted Profile Score (RAPS) this method is able to correct 
for pleiotropy using robust adjusted profile scores. We consider 
as results, causal estimates that agreed in direction and 
magnitude across MR methods, pass nominal significance in 
Table 1. Summary results of the 6 genetic loci associated with serum vitamin D
SNP Nearest gene GX GX SE EA OA EAF p-value
rs3755967 GC -0.089 0.0023 T C 0.28 4.74E-343
rs10741657 CYP2R1 0.031 0.0022 A G 0.4 2.05E-46
rs12785878 NADSYN1/DHCR7 0.036 0.0022 T G 0.75 3.80E-62
rs10745742 AMDHD1 0.019 0.002 T C 0.4 2.10E-20
rs8018720 SEC23A -0.019 0.0027 C G 0.82 1.11E-11
rs17216707 CYP24A1 0.026 0.0027 T C 0.79 8.14E-23
All serum vitamin D markers were associated at genome-wide significance (p < 5 x 10-8); EA: effect allele; OA: other allele, EAF: effect allele frequency; GX: the per-allele effect on 
standard deviation units of the telomere length; GX SE: standard error of GX.
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IVW MR, and did not show evidence of bias from horizontal 
pleiotropy using heterogeneity tests. We used R version 3.4.2 (R 
Core Development Team 2017). 
The MR studies assume that the SNPs (instrumental 
variables) are associated with the outcome only via the 
exposure (32), so we performed sensitivity analysis excluding 
SNPs with potentially pleiotropic effects. To assess the 
instrumental variable analysis “exclusion-restriction” 
assumption we used Ensembl release (http://useast.ensembl.org/
index.html). Ensembl contains a base of SNP phenotypes.
Ethics
This investigation uses published or publicly available 
summary data with no involvement of participants in the study. 
No original data were collected for this manuscript. Ethical 
approval for each of the studies included in the investigation 
can be found in the original publications (including informed 
consent from each subject). 
Results
 
In total, 6 SNPs were identified as instrumental variables for 
serum 25(OH)D, none of which were significantly associated 
with FFM. A list of all SNP associations is shown in Table 
1. The results of MR analysis, displayed as beta-coefficient 
for interested outcomes per increase in serum 25(OH)
D, demonstrate a positive and statistically significant effect 
on total FFM (MR Egger= β:0.019, p= 0.657 and IVW=β: 
0.042, p= 0.038; respectively, Table 2 and Fig. 1), trunk 
(MR Egger= β:0.037, p= 0.406 and IVW=β: 0.045, p=0.023, 
respectively, Table 2 and Fig. 1) FFM. This data suggests 
that each 25 nmol/L increase in serum 25(OH)D is associated 
with an increase of 0.042 kg of total FFM. Serum 25(OH)
D also demonstrated a positive and statistically significant 
effect on arm FFM (Right arm: MR Egger= β:0.043, p= 0.225 
and IVW=β: 0.044, p=0.002; Left arm: MR Egger= β:0.033, 
p= 0.398 and IVW=β: 0.05, p=0.005, respectively, Table 2. 
However, results for leg FFM did not demonstrate a statistically 
significant effect (Right leg: MR Egger= β: -0.025, SE: 0.04, 
p= 0.561 and IVW=β: 0.03, SE: 0.026, p=0.238; Left leg: MR 
Egger= β: -0.008, SE: 0.038, p= 0.838 and IVW=β: 0.039, SE: 
0.023, p=0.1, respectively, Table 2).
Table 2. Results of the Mendelian Randomization (MR) analysis for effects of serum vitamin D on total, trunk, arm and leg fat-
free mass
Exposure Outcome MR Heterogeneity Pleiotropy
Method beta SE p Method Q P-value Intercept SE  p
Vitamin D (Serum 25(OH)D) Total fat-free mass MR Egger    0.019 0.039 0.657 MR-Egger 11.018 0.026 0.001 0.002 0.503
WM 0.031 0.015 0.029
IVW 0.042 0.02 0.038 IVW 12.506 0.029
RAPS 0.036 0.016  0.03
Trunk fat-free mass MR Egger    0.037 0.039 0.406 MR-Egger 11.479  0.022 0.0004 0.002 0.817
WM 0.039 0.015 0.008
IVW 0.045 0.02 0.023 IVW 11.655  0.04
RAPS 0.039 0.017 0.019
Arm fat-free mass (right) MR Egger    0.042 0.029 0.225 MR-Egger 6.415 0.17 0.0001 0.001 0.94
WM 0.042 0.014 0.003
IVW 0.044 0.015 0.002 IVW 6.425 0.267
RAPS 0.042 0.014  0.002
Arm fat-free mass (left) MR Egger    0.033 0.0349 0.398 MR-Egger 8.746 0.068 0.001 0.002 0.589
WM 0.041 0.015 0.007
IVW 0.05 0.018 0.005 IVW 9.499 0.091
RAPS 0.046 0.016 0.005
Leg fat-free mass (right) MR Egger    -0.025 0.0401 0.561 MR-Egger 10.775 0.029 0.003 0.002 0.171
WM 0.015 0.0152 0.334
IVW 0.03 0.0258 0.238 IVW 18.269 0.003
RAPS 0.022 0.021 0.281
Leg fat-free mass (left) MR Egger    -0.008 0.0382 0.838 MR-Egger 9.807 0.044 0.003 0.002 0.215
WM 0.022 0.0148 0.143
IVW 0.039 0.0234 0.1 IVW 15.108 0.009
RAPS 0.031 0.019 0.098
25(OH)D: 25-hydroxy vitamin D; WM: weighted median; IVW: inverse variance weighted; SE: standard error; beta: beta-coefficients; MR: Mendelian randomization; RAPS: robust 
adjusted profile score
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The horizontal pleiotropy test, with very negligible Egger 
regression intercept, also showed a low likelihood of pleiotropy 
for all our estimations (all p > 0.171, Table 2). Further the 
result of the MR-RAPS was identical with the IVW prediction, 
which again indicated a statistically low chance of pleiotropy. 
Heterogeneity tests highlighted no trace of heterogeneity (Table 
2). Furthermore, MR-PRESSO analysis did not indicate any 
outliers for all estimates. Results of leave-one-out method 
demonstrated that the links are not driven by any single SNP.
Discussion
Our results illustrate the potentially causal, positive effect 
of lifetime serum 25(OH)D concentration on total, trunk and 
arm FFM. These findings are in agreement with a number of 
cross-sectional, population-based studies, which have shown 
a positive relationship between serum 25(OH)D status and 
FFM in a wide range of age groups and clinical populations 
[3,17,18]. In a study of 100 adolescents (15.1 ± 1.9 y), serum 
25(OH)D was positively associated with lean body mass and 
inversely with fat mass (18). In a cross-sectional study of 
127 pre-frail and frail elderly people (79.0 ± 7.8 y) in The 
Netherlands, Tieland et al. (3) reported that low 25(OH)D 
status was associated with reduced muscle mass and poorer 
physical performance (3). Additionally, a meta-analysis of 12 
studies with data from 22,590 individuals (mean range 50 – 
88 yrs) reported that sarcopenic individuals had lower blood 
25(OH)D concentrations than non-sarcopenic controls (17). 
Conversely, some studies have reported no such association 
between 25(OH)D and lean body mass (LBM) or FFM (19, 20).
Mechanistically, vitamin D is known to exert its effects 
of muscle tissue both by regulating expression of target 
genes via the vitamin D receptor (VDR) and by non-genomic 
regulation of skeletal muscle intracellular signaling pathways 
(33). In animal models, vitamin D supplementation has been 
demonstrated to activate the mammalian target of rapamycin/
S6 kinase (mTOR/S6K) pathway, which leads to increased 
muscle protein synthesis (MPS) (34) essential for increases in 
muscle protein accrual and size (35). Cell culture models have 
also reported that vitamin D enhances the stimulating effect of 
leucine and insulin on muscle protein synthesis rates (36) and 
promotes myogenic differentiation and reduces the expression 
of myostatin, a known negative regulator of muscle size (37). 
Vitamin D has also been reported to stimulate the expression of 
genes involved in the control of cellular growth (33, 38). These 
varied mechanisms may partly explain the adverse effects of 
low vitamin D status on muscle mass and function.
The present study did not find a statistically significant 
relationship between genetically determined serum 25(OH)D 
concentration and leg FFM. This is not the first study to identify 
a discrepancy in the relationship between 25(OH)D status with 
upper and lower body appendicular lean mass. In a study of 
frail elderly Dutch people (n = 127; mean 79 y) 25(OH)D status 
was associated with appendicular lean mass (ALM) (β=0.012 
[P=0.05]) but was not significantly associated with leg lean 
mass (β=0.008 [P=0.08]) (3). Furthermore, a cross-sectional 
study of the association of 25(OH)D status with muscle strength 
(n = 419; healthy men and women; 20-76 y) has also reported a 
stronger association between 25(OH)D and muscle strength in 
the arms compared to the legs (39). One potential explanation 
for this discrepancy is the reported greater distribution of VDR 
in type 2 muscle fibres (40) which make up a greater proportion 
of upper body skeletal muscle (41-44). Vitamin D affects both 
the diameter and the number of type 2 muscle fibres, which are 
important for not only young athletes but also the elderly, due 
to their capacity to reduce the risk of falls, for example (45, 
46). Greater expression of VDR has been reported to stimulate 
muscle hypertrophy through a number of potential mechanisms 
Figure 1. Scatter plots of the association of the effect of SNP-determined serum 25(OH)D on trunk (A) and total (B) fat-free mass 
Each black point represents an SNP, plotted by the estimate of SNP on serum 25(OH)D level (x-axis, nmol/L) and the estimate of SNP on fat-free mass (y-axis, kg). The slopes of each line 
represent the potential causal associations for each method.
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including increased protein synthesis (47). Furthermore, the 
greater daily utilization of lower extremities, for example, 
due to locomotion and bearing the individuals body weight 
during movement, may provide a superior stimulus for muscle 
hypertrophy. Further research is clearly needed to elucidate the 
mechanisms by which vitamin D differentially affects lower and 
upper body appendicular muscle physiology.
This study highlights the importance of serum vitamin D 
concentrations in accruing and maintaining FFM, which itself 
is associated with lower risk of frailty and mortality (7, 11, 14). 
Addressing vitamin D insufficiency is challenging as the main 
source of vitamin D in humans is sun exposure (48) which 
is unlikely to become a widely accepted and implemented 
strategy. Furthermore, dietary intakes of vitamin D are 
typically low (49) due to low levels in common foodstuffs (50). 
Therefore, at a population level, food fortification with vitamin 
D, and at an individual level, supplementation may be the most 
effective methods to increase 25(OH)D status to sufficient 
levels (5).
A major strength of our study was the large sample 
population study with access to individual participant data of 
high validity and with the relevant SNPs available for both 
25(OH)D serum concentration and FFM. Furthermore, the 
use of the Mendelian randomisation approach allowed us to 
examine the potential causal effects of serum 25(OH)D, largely 
without the disadvantages of confounding or reverse causation. 
A potential limitation of this study is the use of segmental 
bioelectrical impedance analysis (BIA) as the method for 
determining FFM in the UK Biobank cohort. The accuracy 
of BIA measurement is known to be affected by hydration 
status; however the UK Biobank protocol did not specify any 
procedures to standardise some determinants of hydration 
before the assessment. This could potentially lead to 
inaccuracies in the values attained for FFM (51). Furthermore, 
evidence suggests that BIA is less accurate at high BMI levels 
(52) and considering the range of BMI included in the UK 
Biobank cohort, this should be taken into consideration with 
these results.
Conclusions
Evidence for a potentially causal association of serum 
25(OH)D with total, trunk and arm FFM was found. However, 
the relationship between serum 25(OH)D and leg FFM was not 
statistically significant. This finding highlights the importance 
of maintaining sufficient 25(OH)D status throughout the 
life course in order to maintain adequate lean mass, a factor 
associated with multiple chronic disease. Future research should 
address the causal role and potential mechanisms of serum 
25(OH)D on FFM accrual and maintenance as well as the 
apparent lack of effect on leg FFM.
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